12/23/2025
Ready to start a KOL/KEE identification study? Consider ways to leverage these findings beyond the obvious. V2V President Dan Rehal shares three ways pharma companies can use such studies with other stakeholders throughout the company to expand their impact.
Learn more: https://zurl.co/SCf0H